Get the Stockscreener App
2.37
1.72%
0.04
Okyo Pharma Limited stock is traded at $2.37, with a volume of 59,898.
It is up +1.72% in the last 24 hours and down -13.82% over the past month.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
See More
Previous Close:
$2.33
Open:
$2.36
24h Volume:
59,898
Relative Volume:
0.29
Market Cap:
$89.14M
Revenue:
-
Net Income/Loss:
$-13.27M
P/E Ratio:
-14.45
EPS:
-0.164
Net Cash Flow:
$-7.70M
1W Performance:
-10.57%
1M Performance:
-13.82%
6M Performance:
+112.56%
1Y Performance:
+127.88%
1-Day Range:
$2.26
$2.40
1-Week Range:
$2.20
$2.61
52-Week Range:
$0.85
$3.349
Okyo Pharma Limited Stock (OKYO) Company Profile
Compare OKYO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OKYO
Okyo Pharma Limited
|
2.37 | 90.64M | 0 | -13.27M | -7.70M | -0.164 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Okyo Pharma Limited Stock (OKYO) Latest News
OKYO Pharma Limited Breaks Losing Streak — Is the Trend ReversingTrade Ideas & Smart Investment Allocation Tips - beatles.ru
How to escape a deep drawdown in OKYO Pharma LimitedTrade Exit Report & Low Drawdown Trading Strategies - Newser
How to manage a losing position in OKYO Pharma LimitedMarket Trend Summary & High Conviction Buy Zone Alerts - Newser
Published on: 2025-08-20 01:32:22 - Newser
OKYO Pharma Limited stock daily chart insightsQuarterly Trade Review & Safe Capital Investment Plans - Newser
What to do if you’re stuck in OKYO Pharma LimitedTrade Risk Summary & Short-Term High Return Ideas - Newser
OKYO Pharma Limited stock prediction for this weekJuly 2025 Trends & Short-Term Swing Trade Alerts - Newser
Should you hold or exit OKYO Pharma Limited nowPortfolio Growth Summary & Capital Efficiency Focused Ideas - Newser
What candlestick patterns are forming on OKYO Pharma LimitedJuly 2025 Trade Ideas & Stock Portfolio Risk Management - Newser
Quantitative breakdown of OKYO Pharma Limited recent move2025 Fundamental Recap & AI Based Buy and Sell Signals - Newser
What MACD signals say about OKYO Pharma LimitedTrade Volume Report & Growth Oriented Trade Recommendations - Newser
Top chart patterns to watch in OKYO Pharma Limited2025 Buyback Activity & Reliable Momentum Entry Alerts - Newser
Real time breakdown of OKYO Pharma Limited stock performance2025 Big Picture & Daily Stock Trend Watchlist - Newser
Real time alert setup for OKYO Pharma Limited performanceLong Setup & Consistent Income Trade Ideas - Newser
What earnings revisions data tells us about OKYO Pharma LimitedTrade Volume Report & Growth Oriented Trade Recommendations - Newser
Predicting OKYO Pharma Limited trend using moving averagesTrade Volume Report & High Conviction Buy Zone Picks - Newser
Should you wait for a breakout in OKYO Pharma LimitedMarket Movers & Daily Volume Surge Trade Alerts - Newser
How to build a custom watchlist for OKYO Pharma LimitedQuarterly Earnings Summary & Reliable Price Breakout Signals - Newser
Chart Analysts Warn of Resistance Near OKYO Pharma Limited PriceWeekly Market Report & Verified Technical Signals - metrotimes.co.kr
Quant Strategy Flags OKYO Pharma Limited for EntryJuly 2025 Analyst Calls & Free Low Drawdown Momentum Trade Ideas - newsimpact.co.kr
Published on: 2025-08-18 21:51:56 - newsyoung.net
Tools to assess OKYO Pharma Limited’s risk profileJuly 2025 Drop Watch & Community Shared Stock Ideas - Newser
Can OKYO Pharma Limited rally from current levelsTrade Volume Summary & Weekly High Return Forecasts - Newser
Exit strategy if you’re trapped in OKYO Pharma LimitedJuly 2025 Selloffs & Verified Entry Point Detection - Newser
Combining machine learning predictions for OKYO Pharma Limited2025 Historical Comparison & Risk Controlled Daily Plans - Newser
Backtesting results for OKYO Pharma Limited trading strategies2025 Risk Factors & Weekly Hot Stock Watchlists - Newser
Volume spikes in OKYO Pharma Limited stock – what they meanPortfolio Return Summary & AI Powered Trade Plan Recommendations - Newser
Will OKYO Pharma Limited bounce back from current supportGold Moves & Daily Entry Point Alerts - Newser
How to integrate OKYO Pharma Limited into portfolio analysis toolsWatch List & Entry Point Confirmation Signals - Newser
Price Action Confirms Reversal in OKYO Pharma Limited Trend2025 Macro Impact & Stock Timing and Entry Methods - metal.it
Published on: 2025-08-16 14:12:16 - metal.it
Sentiment analysis tools applied to OKYO Pharma LimitedNew Guidance & Free Technical Pattern Based Buy Signals - Newser
Price action breakdown for OKYO Pharma LimitedTrade Risk Assessment & Long Hold Capital Preservation Plans - Newser
Is OKYO Pharma Limited forming a breakout patternQuarterly Investment Review & Precise Trade Entry Recommendations - newsyoung.net
Options Data Show Bullish Bias in OKYO Pharma LimitedJuly 2025 Trends & Technical Pattern Alert System - beatles.ru
How institutional ownership impacts OKYO Pharma Limited stockMarket Movement Recap & Consistent Profit Trading Strategies - Newser
OKYO Pharma Limited stock trend forecastQuarterly Trade Report & Comprehensive Market Scan Insights - Newser
Okyo Pharma Limited Stock (OKYO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):